search
Back to results

Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation

Primary Purpose

Stroke

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
cTBS
cathodal tDCS
sham stimulation
Sponsored by
Adrian Guggisberg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring stroke, brain stimulation, electroencephalography, functional magnetic resonance imaging, functional connectivity

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ischemic or hemorrhagic stroke leading to unilateral deficits in motor function with significant impact on independence and daily activities at the beginning of rehabilitation
  • less than 10 weeks after stroke onset.

Exclusion Criteria:

  • epileptic seizures
  • metallic objects in the brain
  • presence of implants or neural stimulators
  • pregnancy
  • sleep deprivation
  • recent traumatic brain injury
  • delirium or disturbed vigilance
  • inability to participate in 1h treatment sessions
  • severe language comprehension deficits
  • skull breach
  • new stroke lesions during rehabilitation
  • medical complications

Sites / Locations

  • Service de Neurorééducation, Unversity Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Sham Comparator

Arm Label

cTBS

cathodal tDCS

sham stimulation

Arm Description

A transcranial magnetic stimulator (MagPro X100, Medtronic Functional Diagnostics, Skovlunde, Denmark) will deliver continuous bursts of bipolar magnetic pulses exerting an inhibition on the underlying brain tissue (cTBS). The stimulation coil will be placed over the unaffected primary motor cortex. The stimulation protocol implies 200 bursts, each consisting of three pulses applied at 30 Hz, repeated at inter-burst intervals of 167 ms. Two stimulation trains of 30 s, separated by 15 min, will be applied 3 times per week for 3 weeks and will be immediately followed by physical therapy.

A stimulator (NeuroConn GmbH, Illmenau, Germany) will deliver cathodal transcranial direct current stimulation (tDCS) of the unaffected motor cortex. The anode will be placed over the contralateral supraorbital region. Stimulation will be performed for 25 min, 3 times per week for 3 weeks during upper extremity treatment sessions.

This group will receive the same stimulation protocol as used for the active groups except that sham stimuli will be applied. Half of the patients receive sham cTBS, the other half sham tDCS.

Outcomes

Primary Outcome Measures

Change in compound motor score slope at week 4
The Fugl Meyer motor assessment (FMA), the Nine Hole Peg test (expressed as pegs per minute), and the Jamar dynamometer strength of the affected arm are normalized to the healthy arm and averaged to a compound motor score. This score is obtained twice before treatment (at weeks -1 and 0 relative to treatment start), and twice after treatment (at weeks 4 and 8). Primary outcome measure is the change in slope from week 0 to 4 as compared to the slope between week -1 and 0.
Change in alpha-band coherence between the affected motor cortex and the rest of the brain
Calculated from electroencephalography recordings

Secondary Outcome Measures

Change in Fugl Meyer Upper Extremity Motor Score at week 4
Change in Fugl Meyer Upper Extremity Motor Score at week 8
Change in alpha-band coherence between the unaffected motor cortex and the rest of the brain
Change in activity of daily life scale (motor activity log, MAL)
Change in activity of daily life scale (motor activity log, MAL)
Number of adverse events
Number of adverse events

Full Information

First Posted
January 6, 2014
Last Updated
May 11, 2016
Sponsor
Adrian Guggisberg
Collaborators
Swiss National Science Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT02031107
Brief Title
Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation
Official Title
Randomized Controlled Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation in Subacute Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
September 2013 (undefined)
Primary Completion Date
March 2016 (Actual)
Study Completion Date
March 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Adrian Guggisberg
Collaborators
Swiss National Science Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Stroke is a leading cause of adult disability. Non-invasive brain stimulation can induce significant and sustained improvements in functional outcome. However the effect is inconsistent and difficult to predict, in particular in the subacute phase after stroke. Although several different stimulation techniques are available, it is unknown which is suitable for which patient. Objectives: This study has three main objectives: To compare the effects of two techniques of non-invasive brain stimulation (cTBC, continuous theta-burst stimulation; tDCS, direct current transcranial stimulation) on clinical recovery in patients with subacute stroke. To assess the effect of these brain stimulation techniques on brain organization with non-invasive imaging. To find clinical and neural predictors of responsiveness to brain stimulation therapy. Method: 45 patients with ischemic or hemorrhagic stroke will be randomly assigned to one of 3 groups: cTBS, tDCS, or sham stimulation. Each group will receive the corresponding stimulation therapy 3 times per week for 3 weeks, immediately before intensive physical therapy. Before and after the treatment period, standardized assessments of sensorimotor function areas are obtained together with electroencephalography and functional magnetic resonance recordings. These recordings will be used to analyze and compare the neural effects of each treatment modality. Clinical Implication: The results of this study might help optimize and individualize stimulation treatment for patients with subacute stroke. It may hence facilitate the transfer of brain stimulation therapy to routine clinical practice.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
stroke, brain stimulation, electroencephalography, functional magnetic resonance imaging, functional connectivity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
41 (Actual)

8. Arms, Groups, and Interventions

Arm Title
cTBS
Arm Type
Active Comparator
Arm Description
A transcranial magnetic stimulator (MagPro X100, Medtronic Functional Diagnostics, Skovlunde, Denmark) will deliver continuous bursts of bipolar magnetic pulses exerting an inhibition on the underlying brain tissue (cTBS). The stimulation coil will be placed over the unaffected primary motor cortex. The stimulation protocol implies 200 bursts, each consisting of three pulses applied at 30 Hz, repeated at inter-burst intervals of 167 ms. Two stimulation trains of 30 s, separated by 15 min, will be applied 3 times per week for 3 weeks and will be immediately followed by physical therapy.
Arm Title
cathodal tDCS
Arm Type
Active Comparator
Arm Description
A stimulator (NeuroConn GmbH, Illmenau, Germany) will deliver cathodal transcranial direct current stimulation (tDCS) of the unaffected motor cortex. The anode will be placed over the contralateral supraorbital region. Stimulation will be performed for 25 min, 3 times per week for 3 weeks during upper extremity treatment sessions.
Arm Title
sham stimulation
Arm Type
Sham Comparator
Arm Description
This group will receive the same stimulation protocol as used for the active groups except that sham stimuli will be applied. Half of the patients receive sham cTBS, the other half sham tDCS.
Intervention Type
Device
Intervention Name(s)
cTBS
Other Intervention Name(s)
MagPro X100
Intervention Type
Device
Intervention Name(s)
cathodal tDCS
Other Intervention Name(s)
NeuroConn
Intervention Type
Device
Intervention Name(s)
sham stimulation
Primary Outcome Measure Information:
Title
Change in compound motor score slope at week 4
Description
The Fugl Meyer motor assessment (FMA), the Nine Hole Peg test (expressed as pegs per minute), and the Jamar dynamometer strength of the affected arm are normalized to the healthy arm and averaged to a compound motor score. This score is obtained twice before treatment (at weeks -1 and 0 relative to treatment start), and twice after treatment (at weeks 4 and 8). Primary outcome measure is the change in slope from week 0 to 4 as compared to the slope between week -1 and 0.
Time Frame
week 4 after treatment start
Title
Change in alpha-band coherence between the affected motor cortex and the rest of the brain
Description
Calculated from electroencephalography recordings
Time Frame
Week 4
Secondary Outcome Measure Information:
Title
Change in Fugl Meyer Upper Extremity Motor Score at week 4
Time Frame
Week 4
Title
Change in Fugl Meyer Upper Extremity Motor Score at week 8
Time Frame
Week 8
Title
Change in alpha-band coherence between the unaffected motor cortex and the rest of the brain
Time Frame
Week 4
Title
Change in activity of daily life scale (motor activity log, MAL)
Time Frame
Week 4
Title
Change in activity of daily life scale (motor activity log, MAL)
Time Frame
Week 8
Title
Number of adverse events
Time Frame
Week 4
Title
Number of adverse events
Time Frame
Week 8
Other Pre-specified Outcome Measures:
Title
Total Fugl Meyer motor assessment score at week 4
Time Frame
Week 4
Title
Total Fugl Meyer motor assessment score at week 8
Time Frame
Week 8
Title
Change in average velocity in the Nine Hole Peg test at week 4
Description
expressed in pegs/sec
Time Frame
Week 4
Title
Change in average velocity in the Nine Hole Peg test at week 8
Description
expressed in pegs/sec
Time Frame
Week 8
Title
Change in Jamar Dynamometer strength at week 4
Time Frame
Week 4
Title
Change in Jamar Dynamometer strength at week 8
Time Frame
Week 8
Title
Change in Score of the Box and Block test, week 4
Time Frame
Week 4
Title
Change in Score of the Box and Block test, week 8
Time Frame
week 8
Title
Correlation between change in alpha band coherence and clinical improvements
Description
Alpha band coherence is calculated from electroencephalography (EEG) recordings
Time Frame
Week 4
Title
Change in fractional anisotropy of the affected cortico-spinal tract
Description
Calculated from diffusion tensor imaging (DTI) sequences of magnetic
Time Frame
Week 4
Title
Change in correlations of spontaneous fMRI fluctuations within the motor network
Description
Calculated from functional magnetic resonance (fMRI) recordings
Time Frame
Week 4

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ischemic or hemorrhagic stroke leading to unilateral deficits in motor function with significant impact on independence and daily activities at the beginning of rehabilitation less than 10 weeks after stroke onset. Exclusion Criteria: epileptic seizures metallic objects in the brain presence of implants or neural stimulators pregnancy sleep deprivation recent traumatic brain injury delirium or disturbed vigilance inability to participate in 1h treatment sessions severe language comprehension deficits skull breach new stroke lesions during rehabilitation medical complications
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adrian G Guggisberg, MD
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Neurorééducation, Unversity Hospital
City
Geneva
ZIP/Postal Code
1211
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
23941616
Citation
Rizk S, Ptak R, Nyffeler T, Schnider A, Guggisberg AG. Network mechanisms of responsiveness to continuous theta-burst stimulation. Eur J Neurosci. 2013 Oct;38(8):3230-8. doi: 10.1111/ejn.12334. Epub 2013 Aug 14.
Results Reference
background
PubMed Identifier
29223708
Citation
Nicolo P, Magnin C, Pedrazzini E, Plomp G, Mottaz A, Schnider A, Guggisberg AG. Comparison of Neuroplastic Responses to Cathodal Transcranial Direct Current Stimulation and Continuous Theta Burst Stimulation in Subacute Stroke. Arch Phys Med Rehabil. 2018 May;99(5):862-872.e1. doi: 10.1016/j.apmr.2017.10.026. Epub 2017 Dec 7.
Results Reference
derived

Learn more about this trial

Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation

We'll reach out to this number within 24 hrs